The effect of treating herpes zoster with oral acyclovir in preventing postherpetic neuralgia: A meta-analysis

Archives of Internal Medicine

Volumn 157, Issue 8, 1997, Pages 909-912

  Jackson, Jeffrey L ^a   Gibbons, Robert ^b   Meyer, Gregg ^c   Inouye, Lisa ^d  

^a MADIGAN ARMY MEDICAL CENTER   (United States)

^b WALTER REED ARMY MEDICAL CENTER   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^d NAVAL MEDICAL CENTER PORTSMOUTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR;

ARTICLE; BIOAVAILABILITY; DISEASE SEVERITY; DRUG EFFECT; HERPES ZOSTER; HUMAN; IMMUNOCOMPETENCE; META ANALYSIS; ORAL DRUG ADMINISTRATION; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; RASH; VARICELLA ZOSTER VIRUS; VIRUS REACTIVATION;

EID: 0031397092     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.157.8.909     Document Type: Article

References (53)

1. Wentworth BB, Alexander ER. Seroepidemiology of infections due to members of the herpes virus group. Am J Epidemiol. 1971;94:496-507.
2. Ragozzino MW, Melton LJ, Kurland LT, Chu CP, Perry HO. Population based study of herpes zoster and its sequelae. Medicine. 1982;61:310-316.
3. Richards P. Shingles in one family practice. Arch Fam Med. 1996;5:42-46.
4. Hope-Simpson RE. The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med. 1965;58:9-20.
5. McGregor RM. Herpes zoster, chickenpox, and cancer in a general practice. BMJ. 1957;1:84-87.
6. Burgoon CF, Burgoon JS, Baldridge GD. The natural history of herpes zoster. JAMA 1957;164:265-269.
7. Morgas JM, Kierland RR. The outcome of patients with herpes zoster. Arch Dermatol. 1957;75:193-196.
8. Johnson RW. The future of predictors, prevention and therapy in postherpetic neuralgia. Neurology. 1995;45(suppl 8):S70-S72.
9. Morton P, Thomson A. Oral acyclovir in the treatment of herpes zoster in general practice. N Z Med J. 1989;102:93-95.
10. Wood MJ, Ogan PH, McKendrick MW, et al. Efficacy of oral acyclovir treatment of acute herpes zoster. Am J Med. 1988;85:79-83.
11. Huff JC, Bean BB, Balfour HH, et al. Therapy of herpes zoster with oral acyclovir. Am J Med. 1988;85(suppl 2A):84-89.
12. Harding SP, Porter SM. Oral acyclovr in herpes zoster ophthalmicus. Curr Eye Res. 1991;10(suppl):177-182.
13. Whitley RF, Weis H, Gnann JW, et al. Acyclovir with and without prednisone for the treatment of herpes zoster: a randomized, placebo-controlled trial. Ann Intern Med. 1996;125:376-383.
14. Malin JP. A retrospective and an observational study with acyclovir. J Med Virol. 1993;1:102-105.
15. Chalmers T, Smith H, Blackburn B, et al. A method for assessing the quality of a randomized control trial. Control Clin Trials. 1981;2:31-49.
16. Peto R. Why do we need systematic overviews of randomized trials? Stat Med. 1987;6:233-240.
17. Peterslund NA, Seyer-Hanson K, Ipsen J, et al. Acyclovir in herpes zoster. Lancet. 1987;2:827-830.
18. Bean B, Braun C, Balfour HH. Acyclovir therapy for acute herpes zoster. Lancet. 1982;2:118-121.
19. Juel-Jensen BE, Khaun JA, Pavsol G. High dose intravenous acyclovir in the treatment of zoster: a double-blind, placebo controlled trial. J Infect. 1983;6: 31-36.
20. McGill J, McDonald DR, Fall C, McKendrick GDW, Coppleston A. Intravenous acyclovir in acute herpes zoster infection. J Infect. 1983;6:157-161.
21. Van Der Broek PJ, Van der Meer JWM, Mulder JD, Veersteg J, Mattie H. Limited value of acyclovir in the treatment of uncomplicated herpes zoster: a placebo controlled study. Infection. 1984;12:338-341.
22. McKendrick MW, McGill JI, White JE, Wood MJ. Oral acyclovir in acute herpes zoster. BMJ. 1986;29:1529-1532.
23. Wood MJ, McKendrick MW, McGill JI. Oral acyclovir for acute herpes zoster infections in immune-competent adults. Infection. 1987;15(suppl):S9-S13.
24. McKendrick, MW, McGill JI, Wood MJ. Lack of effect of acyclovir on postherpetic neuralgia. BMJ 1989;298:431.
25. Wood MJ, McKendrick MW, Freris MW, et al. Trough plasma acyclovir concentrations and salety of oral acyclovir, 800 mg five times daily for 7 days in elderly patients with herpes zoster. J Antimicrob Chemother 1994;33:1245-1249.
26. Huff JC, Drucker JL, Clemmer A, et al. Effect of oral acyclovir on pain resolution in herpes zoster: a reanalysis. J Med Virol. 1993;1:93-96.
27. McKendrick M, McGill J, Wood M. Lack of effect of acyclovir on postherpetic neuralgia. BMJ. 1989;298:431.
28. Huff JC. Oral acyclovir therapy of acute herpes zoster: a multicenter study. Res Clin Forum. 1987;9:37-45.
29. Mitchell CD, Gehrz RC, Balfour HH, et al. Varicella-zoster-specific immune responses in acute herpes zoster during a placebo-controlled trial of oral acyclovir therapy. Diagn Microbiol Infect Dis. 1986;5:113-126.
30. McKendrick MW, McGill JI, Bell AM, Hickmott E, Burke C. Oral acyclovir for herpes zoster. Lancet. 1984;2(8408):925.
31. Baotian Yu. Treatment of herpes zoster: recombinant alpha-2a-interferon versus acyclovir and vitamin therapy. Chin Med Sci J. 1993;8:38-40.
32. McKendrick MW, Care C, Burke C, Hickmott E, Donald G, McKendrick W. Oral acyclovir in herpes zoster. J Antimicrob Chemother. 1984;14:661-665.
33. Cobo L, Foulks G, Liesegang T, et al. Oral acyclovir in the treatment of acute herpes zoster ophthalmicus. Ophthalmology. 1986;93:763-770.
34. Wassilew { S, Reimlinger S. Oral acyclovir for herpes zoster: a double-blind controlled trial in normal subjects. Br J Dermatol. 1987;117:495-501.
35. Mandal BL, Dunbar EM, Ellis ME, et al. A double-masked, placebo-controlled trial of acyclovir cream in immunocompetent patients with herpes zoster. J Infect. 1988;17:57-63.
36. Benoldi D, Mirizzi S, Zuchi A, Allegra F. Prevention of post-herpetic neuralgia: evaluation of treatment with oral prednisone, oral acyclovir and radiotherapy. Int J Dermatol. 1991;30:288-290.
37. Wood MJ, Johnson RW, McKendrick MW, Taylor J, Mandal BK, Crooks J. A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. N Engl J Med. 1994;330:896-900.
38. Hoang-Xuan T, Buchi ER, Herbort CP, et al. Oral acyclovir for herpes zoster ophthalmicus. Ophthalmology 1992;99:1062-1071.
39. Finn R, Smith MA. Oral acyclovir for herpes zoster. Lancet. 1984;2:575.
40. Surman OS, Flynn T, Schooley RT, et al. A double-blind, placebo-controlled study of oral acyclovir in post-herpetic neuralgia. Psychosomatics. 1991;31: 287-292.
41. Paul JE, Mauskopf JA, Bell L. Cost-consequence models for varicella-zoster virus infections. Pharmacotherapy. 1995;15(5 pt 2):49S-58S.
42. Schmader KE, Studenski S. Are current therapies useful for the prevention of postherpetic neuralgia? J Gen Intern Med. 1989;4:83-89.
43. Crooks RJ, Jones DA, Fiddian AP. Zoster-associated chronic pain: an overview of clinical trials with acyclovir. Scand J Infect. 1991;78:62-68.
44. Silagy C, Gray S. Primary care management of acute herpes zoster: systematic review of evidence from randomized controlled trials. Br J Gen Pract. 1995; 45:39-45.
45. Gnann JW. New antivirals with activity against varicella-zoster virus. Ann Neurol. 1994;35(suppl):S69-S72.
46. Tyring S, Barbarash RA. Nahlik JE, et al. Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. Ann Intern Med. 1995;123:89-96.
47. 1996 Red Book. Montvale, NJ: Medical Economics Data: 1996.
48. Beutner KR, Friedman OJ, Forszpaniak C, Andersen PL, Wood MJ. Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob Agents Chemother. 1995;39:1546-1553.
49. deGreef H. Famciclovir, a new oral antiherpes drug: results of the first controlled clinical study demonstrating its efficacy and safety in the treatment of uncomplicated herpes zoster in immunocompetent patients, Int J Antimicrob Agents. 1995;4:241-246.
50. Duschet P, Schwarz T, Soyer P, et al. Treatment of herpes zoster: recombinant alpha interferon versus acyclovir. Int J Dermatol. 1988;27:193-197.
51. Whitley RJ, Sorivudine: a promising drug for the treatment of varicella-zoster virus infection. Neurology. 1995;45(suppl 8):S73-S75.
52. Crumpacker CS. Ganciclovir. N Engl J Med. 1996;335:721-729.
53. Kost RG, Straus SE. Postherpetic neuralgia - pathogenesis, treatment and prevention. N Engl J Med. 1996;335:32-42.